Advertisement

Hemorrhagic Transformation in the Natural History of Acute Embolic Stroke

  • M. S. Pessin

Abstract

Interest generated by the potential benefits of thrombolytic treatment (especially tissue-type plasminogen activator, t-PA) for acute stroke is tempered by the serious complication of intracranial bleeding. The risks of intracranial bleeding are presently being assessed in several United States and European pilot trials, of different design, using intravenously administered t-PA in acute stroke. Serious intracranial bleeding in these studies refers to bleeding which causes clinical neurologic deterioration not attributable to the original stroke. When the pilot phase of these investigations is complete, control groups of untreated patients will help us compare, in a scientific fashion, intracranial bleeding associated with t-PA. Meanwhile, observations on the natural incidence and clinical computed tomography (CT) features of hemorrhagic transformation (HT) in untreated patients with acute embolic stroke will have to serve as a framework for comparison with acute stroke patients treated with thrombolytic agents.

Keywords

Intracranial Bleeding Compute Tomography Study Hemorrhagic Transformation Cerebral Embolism Embolic Stroke 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brott T, Haley C, Levy D, Barsan W, Sheppard G, Broderick J, Reed R, Marler J (1990) Safety and potential efficacy of tissue plasminogen activator (t-PA) for stroke. Stroke 21:181Google Scholar
  2. 2.
    Cerebral Embolism Study Group (1984) Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Stroke 15:779–789CrossRefGoogle Scholar
  3. 3.
    Del Zoppo GJ, Ferbert A, Otis S, Bruckmann B, Hacke W, Zyroff J, Harker LA, Zeumer H (1988) Local intra arterial fibrinolytic therapy in acute carotid territory stroke. Stroke 19:307–313PubMedCrossRefGoogle Scholar
  4. 4.
    Fisher CM, Adams RD (1951) Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol 10:92–94PubMedGoogle Scholar
  5. 5.
    Fisher CM, Adams RD (1987) Observations on brain embolism with special reference to hemorrhagic infarction. In: Furlan AJ (ed) The heart and stroke. Springer, Berlin Heidelberg New York, pp 17–36CrossRefGoogle Scholar
  6. 6.
    Fisher M, Zito JL, Siva A, DeGirolami U (1984) Hemorrhagic infarction: a clinical and CT study. Stroke 15:192CrossRefGoogle Scholar
  7. 7.
    Hacke W, Zeumer H, Ferbert A, Bruckmann H, Del Zoppo GJ (1988) Intra arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19:1216–1222PubMedCrossRefGoogle Scholar
  8. 8.
    Hart RG, for Cerebral Embolism Study Group (1986) Timing of hemorrhagic transformation of cardioembolic stroke. In: Stober T, Schimrigk K, Ganten D, Sherman DG (eds) Central nervous system control of the heart. Nijhoff, Boston, pp 229–232Google Scholar
  9. 9.
    Hornig CR, Dorndorf W, Agnoli AL (1986) Hemorrhagic cerebral infarction - a prospective study. Stroke 17:179–185PubMedCrossRefGoogle Scholar
  10. 10.
    Jorgensen L, Torvik A (1969) Ischemic cerebrovascular diseases in an autopsy series, part 2. Prevalence, location, pathogenesis, and clinical course of cerebral infarcts. J Neurol Sci 9:285–320PubMedCrossRefGoogle Scholar
  11. 11.
    Lodder J (1984) CT-detected hemorrhagic infarction; relation with the size of the infarct, and the presence of midline shift. Acta Neurol Scand 70:329–335PubMedCrossRefGoogle Scholar
  12. 12.
    Lodder J, Krijne-Kubat B, Broekman J (1986) Cerebral hemorrhagic infarction at autopsy: cardiac embolic cause and the relationship to the cause of death. Stroke 17:626–629PubMedCrossRefGoogle Scholar
  13. 13.
    Mori E, Tabuchi M, Yoshida T, Yamadori A (1988) Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 19:802–812PubMedCrossRefGoogle Scholar
  14. 14.
    Okada Y, Yamaguchi T, Minematsu K, Miyashita T, Sawada T, Sadashima S, Fujishima, Omae T (1989) Hemorrhagic transformation in cerebral embolism. Stroke 20:598–603PubMedCrossRefGoogle Scholar
  15. 15.
    Ott BR, Zamani A, Kleefield J, Funkenstein HH (1986) The clinical spectrum of hemorrhagic infarction. Stroke 17:630–637PubMedCrossRefGoogle Scholar
  16. 16.
    Sherman DG, Hart RG, for the Cerebral Embolism Study Group (1986) Brain hemorrhage in embolic stroke. In: Stober T, Schimrigk K, Ganten D, Sherman DG (eds) Central nervous system control of the heart. Nijhoff, Boston, pp 249–253Google Scholar
  17. 17.
    Theron J, Courtheoux P, Casasco A, Alachkar F, Notan F, Ganem F, Maiza D (1989) Local intraarterial fibrinolysis in the carotid territory. AJNR 10:753–765PubMedGoogle Scholar
  18. 18.
    The tPA Acute Stroke Study Group (1990) An open multicenter study of the safety and efficacy of various doses of tPA in patients with acute stroke. Stroke 21:181Google Scholar
  19. 19.
    von Kummer R, Hutschenreuter M, Wildemann B, Hacke W (1989) Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in acute occlusions of intracranial arteries. J Cereb Blood Flow Metab 9(Suppl 1):S721Google Scholar
  20. 20.
    Weisberg LA (1985) Nonseptic cardiogenic cerebral embolic stroke: clinical-CT correlations. Neurology 35:896–899PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • M. S. Pessin
    • 1
  1. 1.Department of Neurology, New England Medical CenterTufts University School of MedicineBostonUSA

Personalised recommendations